(Q51567062)

English

Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

scientific article published on 25 November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

0 references

Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

A Siebenhofer

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

J Plank

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

A Berghold

3

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

K Horvath

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

P T Sawicki

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

P Beck

6

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

T R Pieber

7

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

publication date

25 November 2004

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

47

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

1895-1905

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

11

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

https://scigraph.springernature.com/pub.10.1007/s00125-004-1545-x

0 references

Events per person year--a dubious concept

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1545-X

21 January 2018

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro in CSII: results of a double-blind crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro lowers postprandial glucose in prepubertal children with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling absorption kinetics of subcutaneous injected soluble insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic and immunologic effects of insulin lispro in gestational diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The physiologic replacement of insulin. An elusive goal

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulins today and beyond

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15599696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-004-1545-X

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15599696

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51567062&oldid=1394254937"